1. P366 A service evaluation of pre-operative nutritional optimisation in patients with Crohn's disease using exclusive enteral nutrition with or without supplementary parenteral nutrition. (25th January 2019) Authors: O'Hanlon, D; Sandall, A; Darakhshan, A; Williams, A; Westcott, E; Patel, K; Irving, P; Lomer, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P318 Ustekinumab: early experience and medium-term outcomes from a UK multi-centre real-world cohort. (25th January 2019) Authors: Gadhok, R; Rao, R; Honap, S; Samaan, M; Harpham-Lockyer, L; Kwok, H; Whitley, L; Ibarra, A; Burgess, N; Seward, E; Parkes, G; Mehta, S; Vega, R; McCartney, S; Bloom, S; Irving, P; Lindsay, J O; Kok, K; Rahman, F Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP06 Dynamic shifts in the balance of gut homing Treg and Th17 cells play a critical role in ulcerative colitis and may predict response to vedolizumab therapy. (25th January 2019) Authors: Hermangild Kottoor, S; Kassam, Z; Pavlidis, P; Alberts, E; Ibraheim, H; Constable, L; Digby-Bell, J; Warren, D; Odukwe, S; Samaan, M; Irving, P; Sanderson, J; Powell, N Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S030 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P656 Malnutrition rates are highest in pre-surgical Crohn's disease when compared with active CD, CD in remission and UC in remission. (25th January 2019) Authors: Sandall, A; Patel, K; Shah, P; O'Hanlon, D; Smith, S; Darakhshan, A; Irving, P; Sanderson, J; Lomer, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P683 Higher serum golimumab concentrations are significantly associated with combined clinical-biochemical remission during maintenance therapy: results from the GO-LEVEL study. (25th January 2019) Authors: Samaan, M; Cunningham, G; Tamilarasan, A G; Rawstron, K; Hawash, K; Beltran, L; Koumoutsos, I; Ray, S; Mawdsley, J; Anderson, S; Sanderson, J; Arkir, Z; Irving, P Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P668 Measured and modelled data suggest that oral administration of V565, a novel domain antibody to TNF-alpha, could be beneficial in the treatment of IBD. (16th January 2018) Authors: Nurbhai, S; West, M; MacDonald, T; Parkes, G; Irving, P; Vossenkaemper, A; Crowe, S Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DOP075 Colonic gamma delta t-cells respond innately to NKG2D ligands and are grossly dysregulated in active inflammatory bowel disease. (16th January 2018) Authors: Dart, R J; Vantourout, P; Laing, A; Digby-Bell, J; Powell, N; Irving, P; Hayday, A Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S081 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P141 Infliximab therapy for inflammatory pouch pathology: a multi-centre retrospective study. (16th January 2018) Authors: Segal, J; Penez, L; Mclaughlin, S; Mullish, B; Quraishi, M; Ding, N; Kandiah, K; Samaan, M; Irving, P; Faiz, O; Clark, S; Hart, A Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DOP086 Low FODMAP diet improves functional-like gastrointestinal symptoms but reduces bifidobacteria and faecalibacterium prausnitzii in Quiescent inflammatory bowel disease: a randomised controlled trial and metagenomic analysis. (16th January 2018) Authors: Cox, S; Stagg, A; Fromentin, S; Ehrlich, D; McCarthy, N; Galleron, N; Levenez, F; Lomer, M; Lindsay, J; Irving, P; Whelan, K Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S087 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PWE-109 Measurement of Infliximab and Anti-Infliximab Antibodies - Analytical Aspects and Clinical Implications. (4th June 2013) Authors: Unsworth, N; Arkir, Z; Irving, P; Ward, M G; Richards, G Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗